Concepedia

Michael Jäger

MJ

7

Publications

396

Citations

7

H-Index

2005

Active since

Affiliations

University of Bern(Current)

Ludwig-Maximilians-Universität München

Witten/Herdecke University

Neovii Biotech (Germany)

University Hospital of Bern

Michael Jäger is an author at University of Bern specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

2005–2016

7

Publications

7

Immunotherapy of malignant ascites with trifunctional antibodies

M. M. Heiss, Michael A. Ströhlein, Michael Jäger et al. · International Journal of Cancer · 2005 · 118 citations · Full text

, , +15

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study

Martin Sebastian, Bernward Passlick, H. Friccius-Quecke et al. · Cancer Immunology Immunotherapy · 2007 · 98 citations · Full text

, , +12

Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial

Michael A. Ströhlein, Florian Lordick, Dominik Rüttinger et al. · Onkologie · 2011 · 75 citations · Full text

Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis

Michael A. Ströhlein, Robert Siegel, Michael Jäger et al. · Journal of Experimental & Clinical Cancer Research · 2009 · 50 citations · Full text

Age-dependent visual exploration during simulated day- and night driving on a motorway: a cross-sectional study

Prabitha Urwyler, Nicole Gruber, René M. Müri et al. · BMC Geriatrics · 2015 · 26 citations · Full text

Rows per page

1–5 of 7